{
      "StudyFieldsResponse": {
            "APIVrs": "1.01.05",
            "DataVrs": "2022:10:06 23:25:58.836",
            "Expression": "mesenchymal stem Rheumatoid Arthritis",
            "NStudiesAvail": 430108,
            "NStudiesFound": 18,
            "MinRank": 1,
            "MaxRank": 1000,
            "NStudiesReturned": 18,
            "FieldList": [
                  "PrimaryOutcomeTimeFrame",
                  "ReferenceCitation",
                  "ReferencePMID",
                  "ReferenceType",
                  "RemovedCountry",
                  "ResponsiblePartyInvestigatorAffiliation",
                  "ResponsiblePartyInvestigatorFullName",
                  "ResponsiblePartyInvestigatorTitle",
                  "ResponsiblePartyOldNameTitle",
                  "ResponsiblePartyOldOrganization",
                  "ResponsiblePartyType",
                  "ResultsFirstPostDate",
                  "ResultsFirstPostDateType",
                  "ResultsFirstPostedQCCommentsDate",
                  "ResultsFirstPostedQCCommentsDateType",
                  "NCTId"
            ],
            "StudyFields": [
                  {
                        "Rank": 1,
                        "PrimaryOutcomeTimeFrame": [
                              "At 0 and 6 months follow up"
                        ],
                        "ReferenceCitation": [
                              "\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C, DelaRosa O, Tagarro I, D\u00edaz-Gonz\u00e1lez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis. 2017 Jan;76(1):196-202. doi: 10.1136/annrheumdis-2015-208918. Epub 2016 Jun 7.",
                              "Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol. 2012 Jan;31(1):157-61. doi: 10.1007/s10067-011-1816-0. Epub 2011 Aug 12.",
                              "Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H, Zhu D, Wu M, Liu Y. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013 Dec 15;22(24):3192-202. doi: 10.1089/scd.2013.0023. Epub 2013 Oct 4."
                        ],
                        "ReferencePMID": [
                              "27269294",
                              "21837432",
                              "23941289"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [
                              "Mashhad University of Medical Sciences"
                        ],
                        "ResponsiblePartyInvestigatorFullName": [
                              "Dr. Mojgan Mohammadi"
                        ],
                        "ResponsiblePartyInvestigatorTitle": [
                              "Associate professor"
                        ],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Principal Investigator"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03333681"
                        ]
                  },
                  {
                        "Rank": 2,
                        "PrimaryOutcomeTimeFrame": [
                              "six months"
                        ],
                        "ReferenceCitation": [
                              "Wang H, Wu M, Liu Y. Are mesenchymal stem cells major sources of safe signals in immune system? Cell Immunol. 2012;272(2):112-6. doi: 10.1016/j.cellimm.2011.10.010. Epub 2011 Oct 29. Review.",
                              "Wang L, Ji H, Zhou J, Xie J, Zhong Z, Li M, Bai W, Li N, Zhang Z, Wang X, Zhu D, Liu Y, Wu M. Therapeutic potential of umbilical cord mesenchymal stromal cells transplantation for cerebral palsy: a case report. Case Rep Transplant. 2013;2013:146347. doi: 10.1155/2013/146347. Epub 2013 Mar 3."
                        ],
                        "ReferencePMID": [
                              "22138499",
                              "23533920"
                        ],
                        "ReferenceType": [
                              "background",
                              "background"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01547091"
                        ]
                  },
                  {
                        "Rank": 3,
                        "PrimaryOutcomeTimeFrame": [
                              "12 months"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT02643823"
                        ]
                  },
                  {
                        "Rank": 4,
                        "PrimaryOutcomeTimeFrame": [
                              "1month",
                              "1month",
                              "1month"
                        ],
                        "ReferenceCitation": [
                              "Shadmanfar S, Labibzadeh N, Emadedin M, Jaroughi N, Azimian V, Mardpour S, Kakroodi FA, Bolurieh T, Hosseini SE, Chehrazi M, Niknejadi M, Baharvand H, Gharibdoost F, Aghdami N. Intra-articular knee implantation of autologous bone marrow-derived mesenchymal stromal cells in rheumatoid arthritis patients with knee involvement: Results of a randomized, triple-blind, placebo-controlled phase 1/2 clinical trial. Cytotherapy. 2018 Apr;20(4):499-506. doi: 10.1016/j.jcyt.2017.12.009. Epub 2018 Feb 7."
                        ],
                        "ReferencePMID": [
                              "29428486"
                        ],
                        "ReferenceType": [
                              "derived"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01873625"
                        ]
                  },
                  {
                        "Rank": 5,
                        "PrimaryOutcomeTimeFrame": [
                              "12 months"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01985464"
                        ]
                  },
                  {
                        "Rank": 6,
                        "PrimaryOutcomeTimeFrame": [
                              "Up to day 28\u00b13",
                              "Up to day 28\u00b13",
                              "Up to day 28\u00b13",
                              "Up to day 28\u00b13",
                              "Up to day 28\u00b13",
                              "Up to day 28\u00b13",
                              "28\u00b13 days",
                              "Up to day 28\u00b13"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT04971980"
                        ]
                  },
                  {
                        "Rank": 7,
                        "PrimaryOutcomeTimeFrame": [
                              "24 weeks",
                              "24 weeks"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03798028"
                        ]
                  },
                  {
                        "Rank": 8,
                        "PrimaryOutcomeTimeFrame": [
                              "12 months"
                        ],
                        "ReferenceCitation": [
                              "Vij R, Stebbings KA, Kim H, Park H, Chang D. Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial. Stem Cell Res Ther. 2022 Mar 3;13(1):88. doi: 10.1186/s13287-022-02763-w."
                        ],
                        "ReferencePMID": [
                              "35241141"
                        ],
                        "ReferenceType": [
                              "derived"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [
                              "March 22, 2022"
                        ],
                        "ResultsFirstPostDateType": [
                              "Actual"
                        ],
                        "ResultsFirstPostedQCCommentsDate": [
                              "February 24, 2022"
                        ],
                        "ResultsFirstPostedQCCommentsDateType": [
                              "Actual"
                        ],
                        "NCTId": [
                              "NCT03691909"
                        ]
                  },
                  {
                        "Rank": 9,
                        "PrimaryOutcomeTimeFrame": [
                              "Four year follow-up"
                        ],
                        "ReferenceCitation": [
                              "Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, Aletaha D, van Riel PL. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009 Jun;68(6):954-60. doi: 10.1136/ard.2007.084459. Epub 2008 May 19.",
                              "Delgado DA, Lambert BS, Boutris N, McCulloch PC, Robbins AB, Moreno MR, Harris JD. Validation of Digital Visual Analog Scale Pain Scoring With a Traditional Paper-based Visual Analog Scale in Adults. J Am Acad Orthop Surg Glob Res Rev. 2018 Mar 23;2(3):e088. doi: 10.5435/JAAOSGlobal-D-17-00088. eCollection 2018 Mar.",
                              "Wang L, Huang S, Li S, Li M, Shi J, Bai W, Wang Q, Zheng L, Liu Y. Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study. Drug Des Devel Ther. 2019 Dec 19;13:4331-4340. doi: 10.2147/DDDT.S225613. eCollection 2019.",
                              "Ghoryani M, Shariati-Sarabi Z, Tavakkol-Afshari J, Ghasemi A, Poursamimi J, Mohammadi M. Amelioration of clinical symptoms of patients with refractory rheumatoid arthritis following treatment with autologous bone marrow-derived mesenchymal stem cells: A successful clinical trial in Iran. Biomed Pharmacother. 2019 Jan;109:1834-1840. doi: 10.1016/j.biopha.2018.11.056. Epub 2018 Nov 26."
                        ],
                        "ReferencePMID": [
                              "18490431",
                              "30211382",
                              "31908418",
                              "30551438"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background",
                              "background"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT05003934"
                        ]
                  },
                  {
                        "Rank": 10,
                        "PrimaryOutcomeTimeFrame": [
                              "12 months after infusion"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03828344"
                        ]
                  },
                  {
                        "Rank": 11,
                        "PrimaryOutcomeTimeFrame": [
                              "14 days following infusion",
                              "48 hours following infusion",
                              "30 minutes following infusion",
                              "52 weeks following infusion"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [
                              "MetroHealth Medical Center"
                        ],
                        "ResponsiblePartyInvestigatorFullName": [
                              "Nora G. Singer"
                        ],
                        "ResponsiblePartyInvestigatorTitle": [
                              "Physician"
                        ],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Principal Investigator"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03186417"
                        ]
                  },
                  {
                        "Rank": 12,
                        "PrimaryOutcomeTimeFrame": [
                              "52 weeks"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT04170426"
                        ]
                  },
                  {
                        "Rank": 13,
                        "PrimaryOutcomeTimeFrame": [
                              "1 month"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03067870"
                        ]
                  },
                  {
                        "Rank": 14,
                        "PrimaryOutcomeTimeFrame": [
                              "4 weeks follow-up after treatment"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT03618784"
                        ]
                  },
                  {
                        "Rank": 15,
                        "PrimaryOutcomeTimeFrame": [
                              "0, 4, 8,12, 24, 36,48 weeks after treatment"
                        ],
                        "ReferenceCitation": [
                              "Poupon RE, Lindor KD, Cauch-Dudek K, Dickson ER, Poupon R, Heathcote EJ. Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis. Gastroenterology. 1997 Sep;113(3):884-90.",
                              "Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH, Witteman BJ, van Erpecum KJ, van Buuren HR; Dutch PBC Study Group. Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterology. 2009 Apr;136(4):1281-7. doi: 10.1053/j.gastro.2009.01.003. Epub 2009 Jan 14.",
                              "Poupon R. Primary biliary cirrhosis: a 2010 update. J Hepatol. 2010 May;52(5):745-58. doi: 10.1016/j.jhep.2009.11.027. Epub 2010 Feb 18. Review.",
                              "Silveira MG, Brunt EM, Heathcote J, Gores GJ, Lindor KD, Mayo MJ. American Association for the Study of Liver Diseases endpoints conference: design and endpoints for clinical trials in primary biliary cirrhosis. Hepatology. 2010 Jul;52(1):349-59. doi: 10.1002/hep.23637."
                        ],
                        "ReferencePMID": [
                              "9287980",
                              "19208346",
                              "20347176",
                              "20578151"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background",
                              "background"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [
                              "Beijing 302 Hospital"
                        ],
                        "ResponsiblePartyInvestigatorFullName": [
                              "Fu-Sheng Wang"
                        ],
                        "ResponsiblePartyInvestigatorTitle": [
                              "Director of both the Research Center for Biological Therapy and the Beijing Institute of Translational Hepatology"
                        ],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Principal Investigator"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01662973"
                        ]
                  },
                  {
                        "Rank": 16,
                        "PrimaryOutcomeTimeFrame": [
                              "baseline and 96 weeks",
                              "0,12, 24, 36, 48, 72, 96 weeks after treatment"
                        ],
                        "ReferenceCitation": [
                              "Czaja AJ. Advances in the current treatment of autoimmune hepatitis. Dig Dis Sci. 2012 Aug;57(8):1996-2010. doi: 10.1007/s10620-012-2151-2. Epub 2012 Apr 3. Review.",
                              "Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology. 2007 Oct;46(4):1138-45.",
                              "Czaja AJ. Promising pharmacological, molecular and cellular treatments of autoimmune hepatitis. Curr Pharm Des. 2011;17(29):3120-40. Review.",
                              "Gossard AA, Lindor KD. Autoimmune hepatitis: a review. J Gastroenterol. 2012 May;47(5):498-503. doi: 10.1007/s00535-012-0586-z. Epub 2012 Apr 17. Review.",
                              "Malekzadeh Z, Haghazali S, Sepanlou SG, Vahedi H, Merat S, Sotoudeh M, Nasseri-Moghaddam S, Malekzadeh R. Clinical features and long term outcome of 102 treated autoimmune hepatitis patients. Hepat Mon. 2012 Feb;12(2):92-9. doi: 10.5812/hepatmon.808. Epub 2012 Feb 29.",
                              "Yi T, Song SU. Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications. Arch Pharm Res. 2012 Feb;35(2):213-21. doi: 10.1007/s12272-012-0202-z. Epub 2012 Feb 28. Review.",
                              "Holbro A, Abinun M, Daikeler T. Management of autoimmune diseases after haematopoietic stem cell transplantation. Br J Haematol. 2012 May;157(3):281-90. doi: 10.1111/j.1365-2141.2012.09070.x. Epub 2012 Feb 24. Review."
                        ],
                        "ReferencePMID": [
                              "22476586",
                              "17668882",
                              "21902661",
                              "22526272",
                              "22509185",
                              "22370776",
                              "22360687"
                        ],
                        "ReferenceType": [
                              "background",
                              "background",
                              "background",
                              "background",
                              "background",
                              "background",
                              "background"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [
                              "Beijing 302 Hospital"
                        ],
                        "ResponsiblePartyInvestigatorFullName": [
                              "Fu-Sheng Wang"
                        ],
                        "ResponsiblePartyInvestigatorTitle": [
                              "Director of both the Research Center for Biological Therapy and the Beijing Institute of Translational Hepatology"
                        ],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Principal Investigator"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01661842"
                        ]
                  },
                  {
                        "Rank": 17,
                        "PrimaryOutcomeTimeFrame": [
                              "6 months follow up after the first administration"
                        ],
                        "ReferenceCitation": [
                              "\u00c1lvaro-Gracia JM, Jover JA, Garc\u00eda-Vicu\u00f1a R, Carre\u00f1o L, Alonso A, Marsal S, Blanco F, Mart\u00ednez-Taboada VM, Taylor P, Mart\u00edn-Mart\u00edn C, DelaRosa O, Tagarro I, D\u00edaz-Gonz\u00e1lez F. Intravenous administration of expanded allogeneic adipose-derived mesenchymal stem cells in refractory rheumatoid arthritis (Cx611): results of a multicentre, dose escalation, randomised, single-blind, placebo-controlled phase Ib/IIa clinical trial. Ann Rheum Dis. 2017 Jan;76(1):196-202. doi: 10.1136/annrheumdis-2015-208918. Epub 2016 Jun 7."
                        ],
                        "ReferencePMID": [
                              "27269294"
                        ],
                        "ReferenceType": [
                              "derived"
                        ],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01663116"
                        ]
                  },
                  {
                        "Rank": 18,
                        "PrimaryOutcomeTimeFrame": [
                              "6 months post-op"
                        ],
                        "ReferenceCitation": [],
                        "ReferencePMID": [],
                        "ReferenceType": [],
                        "RemovedCountry": [],
                        "ResponsiblePartyInvestigatorAffiliation": [],
                        "ResponsiblePartyInvestigatorFullName": [],
                        "ResponsiblePartyInvestigatorTitle": [],
                        "ResponsiblePartyOldNameTitle": [],
                        "ResponsiblePartyOldOrganization": [],
                        "ResponsiblePartyType": [
                              "Sponsor"
                        ],
                        "ResultsFirstPostDate": [],
                        "ResultsFirstPostDateType": [],
                        "ResultsFirstPostedQCCommentsDate": [],
                        "ResultsFirstPostedQCCommentsDateType": [],
                        "NCTId": [
                              "NCT01413061"
                        ]
                  }
            ]
      }
}